MediMix Oncology
  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
Browse Tag

highlight

178 Articles
SIOG 2024

Highlight SIOG 2024

WonderMedia Team
wondermedia
25 November 2024

In this video, Prof Dr Hans Wildiers shares his key take-aways from the...

Proffered paper session

Admin
Admin
10 October 2024

Mini Oral Session: GI upper

Admin
Admin
8 October 2024

Proffered paper session on CNS

WonderMedia Team
wondermedia
30 September 2024

Proffered paper session: NETs and endocrine tumours

WonderMedia Team
wondermedia
27 September 2024

Proffered paper & mini oral session: Prostate cancer

WonderMedia Team
wondermedia
27 September 2024

Mini oral 3: NSCLC metastatic

WonderMedia Team
wondermedia
26 September 2024

Mini oral session: GI, lower digestive

WonderMedia Team
wondermedia
26 September 2024

Mini Oral 2: mBC

WonderMedia Team
wondermedia
26 September 2024

Mini oral 2: NSCLC non-metastatic

WonderMedia Team
wondermedia
25 September 2024
« Previous 1 2 3 4 5 6 … 18 Next »

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok